(Q28344947)

English

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis

scientific article

In more languages

Statements

scholarly article

0 references

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis (English)

0 references

0 references

invasive aspergillosis

1 reference

based on heuristic

inferred from title

author name string

J Roberts

1

0 references

K Schock

2

0 references

S Marino

3

0 references

V T Andriole

4

0 references

language of work or name

0 references

publication date

December 2000

0 references

Antimicrobial Agents and Chemotherapy

0 references

44

0 references

12

0 references

3381-8

0 references

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

In vitro activity of a new oral triazole, BMS-207147 (ER-30346)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

20 March 2017

The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Aspergillus infections: problems in diagnosis and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Fungal infections in patients with acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Saperconazole therapy in a rabbit model of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

29 September 2017

Efficacy of fluconazole in experimental invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

2 June 2018

The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

2 June 2018

New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

27 November 2018

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90209

27 November 2018

Aspergillosis complicating neoplastic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New antifungal agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy in experimental invasive aspergillosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp

1 reference

https://pubmed.ncbi.nlm.nih.gov/11083644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.44.12.3381-3388.2000

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28344947&oldid=1576379458"